or wait 15s
Japan-based Ono Pharmaceutical has entered into a drug discovery partnership agreement with US-based Aitia, In
DKSH has signed an agreement to acquire P.R. Chemicals, a specialties distributor of Active Pharmaceutical Ing
Haisco Pharmaceutical Group Co. has entered into an exclusive licensing agreement with Sentivera, a new US ven
Indian biotechnology company Immunoscript Life Science will receive up to $8.9 million from Norway-based Coali
Researchers from the National University of Singapore (NUS) Medicine and China's Tianjin Medical University Ge
South Korea based Rznomics Inc, a biopharmaceutical company specialising in the development of RNA-based gene
Rayence, a South Korea-based leader in digital X-ray detectors and medical imaging solutions, has announced th
Enginprime Medical, a developer of percutaneous ventricular assist device (pVAD) technology, has announced the
Viral Vector Manufacturing Facility (VVMF), Australia’s first viral vector Contract Development and Manu
Japan-based Hodogaya Chemical has established a subsidiary to promote the nucleic acid therapeutics CDMO busin
The Race TO GREENER PHARMA
A greener pharmaceutical industry will not be built through sustainability reports alone. It will be built in the factories where medicines are made. Across Asia-Pacific (APAC), this is becoming an increasingly important test for the industry as rising resource costs, climate risks, customer expectations and regulatory scrutiny converge. For Contract Development and Manufacturing Organisations (CDMOs), the challenge is particularly significant: the choices made on the factory floor — from energy and water use to solvents, waste, production technologies and sourcing — can determine the environmental footprint of medicines long before they reach patients. With manufacturing estimated to account for around 80 per cent of a pharmaceutical company’s environmental footprint, the stakes are high. So, what does greener pharmaceutical manufacturing actually look like in practice? We have examined the latest Environmental, Social and Governance (ESG) and sustainability reports of eight leading APAC CDMOs to find out where the industry is making real progress, and where the biggest challenges remain.
For Feedback, please email us at: coo@mmactiv.com
GPCE Brisbane 2026
Reed Exhibitions Australia Pty Ltd
info@gpce.com.au https://www.gpce.com.au/brisbane/en-gb.htmlBrisbane Convention & Exhibition Centre (BCEC)
"13th Edition of Global Conference on Pharmaceutics and Novel Drug Delivery Systems"
Magnus Group LLC
pharma@magnusconference.com https://pharmaceuticsconference.com/Rome, Italy
2nd Annual AI Visionaries Summit 2026
Magnivel International Group
upkar@magnivelinternational.org https://magnivelinternational.com/conferences/2nd-annual-ai-visionaries-summit-2026Singapore
